BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2011
View Archived Issues
Phase II trial investigates SPD-503 in new indication
Read More
Genmab achieves milestone in collaboration with Lundbeck
Read More
Putative biomarker in non-cystic fibrosis bronchiectasis identified
Read More
Scientists at AstraZeneca present new therapy for AML
Read More
Malaria vaccine is safe and immunogenic in phase Ib study
Read More
Dual dopamine D2 receptor/NET inhibitors identified by Astellas Pharma
Read More
Novel glucocorticoid receptor agonist shows anti-inflammatory activity
Read More
New dipeptidyl peptidase 4 inhibitors patented by Chinese company
Read More
Novel p140-TrkA inhibitors prepared by Array BioPharma
Read More
Scientists at Mitsubishi Tanabe Pharma disclose new GPR119 receptor agonists
Read More
Abilify approved in Canada for use in new patient population
Read More
Dainippon Sumitomo Pharma presents novel amide derivatives
Read More
Merck & Co. synthesizes new PRCP inhibitors
Read More
Merck & Co. and Roche begin clinical collaboration for HCV infection
Read More
Phase II AX-200 study does not meet endpoints
Read More
Galapagos announces proof-of-mechanism milestone in alliance with GSK
Read More
Phase III study begins for ALKS-9070
Read More
New fenofibrate products launched in Japan for hyperlipidemia
Read More
Pharmasset to amend design of phase IIb PSI-938 trial
Read More
FDA approves Advate for new indication
Read More
CHMP issues recommendation on marketing authorization Esmya
Read More
Roche's Zelboraf receives CHMP opinion
Read More
ISTA Pharmaceuticals declines Valeant's acquisition offer
Read More
LabCorp acquires Orchid Cellmark
Read More
Zalicus begins phase I Z-944 study
Read More
